A 56-year-old male construction worker with stage 3 chronic kidney disease presents with pitting edema, mild bilateral crackles, and hyperkalemia. Which nursing intervention should be prioritized to address the risk of cardiac dysrhythmias?

B) Administer sodium polystyrene sulfonate as prescribed.

A) Encourage increased fluid intake to dilute serum potassium.

B) Administer sodium polystyrene sulfonate as prescribed.

C) Advise the patient to consume foods high in potassium.

D) Monitor the patient's blood pressure every 2 hours.

A 56-year-old male with stage 3 chronic kidney disease presents with pitting edema, crackles at lung bases, and hyperkalemia. Which nursing intervention is the most appropriate to prioritize for this patient?

B) Administer a potassium-binding resin as prescribed to address hyperkalemia.

A) Educate the patient on the importance of fluid restriction to manage edema.

B) Administer a potassium-binding resin as prescribed to address hyperkalemia.

C) Increase the patient's protein intake to prevent further weight loss.

D) Encourage the patient to increase physical activity to improve circulation.

A patient with chronic kidney disease (CKD) presents with persistent hyperkalemia and anemia. Which of the following interventions should the nurse prioritize to address these conditions effectively while considering the patient's overall management plan?

C) Educate the patient on reducing dietary potassium and consider erythropoiesis-stimulating agents.

A) Increase dietary potassium intake to counteract anemia.

B) Administer a phosphate binder to reduce serum phosphorus levels.

C) Educate the patient on reducing dietary potassium and consider erythropoiesis-stimulating agents.

D) Suggest increasing fluid intake to improve kidney function and reduce hyperkalemia.

A patient with chronic kidney disease presents with persistent hyperkalemia, a metallic taste, and decreased appetite, along with recent laboratory findings showing a decrease in hemoglobin to 10.8 g/dL. Which nursing intervention is the priority to address these findings?

B) Educate the patient on potassium-restricted dietary choices to manage hyperkalemia.

A) Administer a phosphate binder as prescribed to control hyperphosphatemia.

B) Educate the patient on potassium-restricted dietary choices to manage hyperkalemia.

C) Initiate erythropoiesis-stimulating agents to correct anemia.

D) Arrange a consultation with a nutritionist to improve dietary adherence.

A patient with chronic kidney disease is experiencing hyperkalemia, with a potassium level of 5.8 mEq/L, despite dietary adjustments. The healthcare team is considering interventions to address this issue. Which of the following interventions is most appropriate for the nurse to anticipate in managing this patient’s hyperkalemia?

B) Initiate treatment with a potassium-binding resin.

A) Administer an intravenous calcium gluconate infusion.

B) Initiate treatment with a potassium-binding resin.

C) Encourage an increase in dietary intake of potassium-rich foods.

D) Administer a loop diuretic to promote potassium excretion.

A patient with chronic kidney disease presents with elevated potassium levels and reports occasional palpitations. Considering the current clinical scenario, which nursing intervention is the most appropriate to address the hyperkalemia?

B) Educate the patient to avoid high-potassium foods such as bananas and oranges.

A) Encourage the patient to increase fluid intake to dilute potassium levels.

B) Educate the patient to avoid high-potassium foods such as bananas and oranges.

C) Administer a loop diuretic as prescribed to enhance potassium excretion.

D) Recommend the patient use salt substitutes to improve food flavor.

A patient with chronic kidney disease presents with increased fatigue, shortness of breath, elevated potassium levels, and signs of fluid overload. The healthcare team suspects congestive heart failure. Which nursing intervention is most appropriate to prioritize in this scenario?

C) Monitor daily weights and fluid intake/output closely.

A) Administer a potassium-sparing diuretic to manage fluid overload.

B) Initiate oxygen therapy to address shortness of breath.

C) Monitor daily weights and fluid intake/output closely.

D) Increase dietary potassium to address electrolyte imbalance.

A patient with chronic kidney disease presents with increased fatigue, shortness of breath, jugular venous distention, crackles at the lung bases, and hyperkalemia. Which nursing intervention is most appropriate to prioritize in this situation?

A) Administer a potassium-binding resin to address hyperkalemia

B) Apply oxygen therapy to relieve shortness of breath

C) Restrict fluid intake to manage possible heart failure

D) Increase dietary sodium to correct hyponatremia

A patient with early-stage congestive heart failure and hyperkalemia is transitioning from a potassium-sparing diuretic to a loop diuretic. Which nursing intervention is most appropriate to prioritize during this medication adjustment?

A) Monitor the patient's potassium levels daily.

B) Instruct the patient to increase fluid intake to prevent dehydration.

C) Advise the patient to avoid foods high in sodium to prevent fluid retention.

D) Encourage the patient to engage in moderate exercise to improve cardiac function.

A patient with early-stage congestive heart failure is being managed for fluid overload and hyperkalemia. After switching from a potassium-sparing diuretic to a loop diuretic, the patient shows slight improvement in symptoms but still experiences fatigue. The cardiology team is considering adding an ACE inhibitor. What is the primary nursing consideration when monitoring for potential complications after initiating ACE inhibitor therapy in this patient?

B) Assess for orthostatic hypotension

A) Monitor for signs of hypokalemia

B) Assess for orthostatic hypotension

C) Evaluate for increased shortness of breath

D) Check for signs of hypernatremia

renal diet - Nursing Case Study

Pathophysiology

• Primary mechanism: Reduced kidney function leads to decreased filtration of waste products like urea and creatinine. A renal diet limits protein intake to minimize these waste products, thus reducing the burden on the kidneys and preventing further damage.

• Secondary mechanism: Impaired kidney function affects electrolyte balance, particularly potassium and phosphorus. A renal diet restricts high-potassium and high-phosphorus foods to prevent hyperkalemia and hyperphosphatemia, which can lead to cardiac complications and bone disorders, respectively.

• Key complication: Fluid retention due to compromised kidney function can exacerbate hypertension and edema. Controlling sodium intake in the renal diet helps manage fluid balance and blood pressure, reducing cardiovascular strain.

Patient Profile

Demographics:

56-year-old male, construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, Stage 3 Chronic Kidney Disease

• Current medications: Lisinopril, Metformin, Atorvastatin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Increasing fatigue and swelling in lower extremities

• Key symptoms: Shortness of breath, nausea, decreased urine output, persistent metallic taste in mouth

• Vital signs: Blood pressure 148/92 mmHg, heart rate 88 bpm, respiratory rate 22 breaths per minute, temperature 98.2°F, oxygen saturation 94% on room air

Section 1

The initial assessment of the 56-year-old male construction worker reveals further insights into his current condition. Upon examination, the swelling in his lower extremities is noted to be pitting edema, rated at 2+, which is consistent with fluid retention. Auscultation of the lungs indicates mild bilateral crackles at the bases, suggesting fluid accumulation. His abdomen is soft but slightly distended, and there is tenderness upon palpation. A neurological assessment shows the patient is alert and oriented, though he reports experiencing intermittent dizziness. Additionally, the persistent metallic taste in his mouth has led to decreased appetite, contributing to a recent weight loss of 5 pounds over the past month.

Recent laboratory tests provide more information on his renal function and electrolyte balance. Serum creatinine has increased to 2.5 mg/dL, and blood urea nitrogen (BUN) is elevated at 45 mg/dL, indicating worsening renal function. Electrolyte panels reveal hyperkalemia, with potassium levels at 5.8 mEq/L, and mild hyperphosphatemia, with phosphorus levels at 5.2 mg/dL. These findings are consistent with his stage 3 chronic kidney disease progression and create a significant risk for cardiac dysrhythmias. Furthermore, his hemoglobin is slightly low at 11.4 g/dL, suggesting the onset of anemia, a common complication in chronic kidney disease patients due to decreased erythropoietin production.

In response to these findings, the healthcare team initiates adjustments to his renal diet, emphasizing the importance of limiting high-potassium and high-phosphorus foods, while ensuring adequate caloric intake to prevent further weight loss. An increase in his lisinopril dosage is being considered to better manage his blood pressure and reduce proteinuria, thereby slowing the progression of kidney damage. The patient is also educated about the signs and symptoms of hyperkalemia and instructed to report any palpitations or muscle weakness immediately. These interventions aim to stabilize his condition and prevent further complications, highlighting the critical role of dietary adherence and medication management in chronic kidney disease care.

Section 2

Several weeks later, the patient returns for a follow-up appointment, and the clinical team conducts a thorough reassessment to evaluate the effectiveness of the interventions. Upon examination, the patient reports feeling slightly less dizzy, but continues to experience a persistent metallic taste, which has further decreased his appetite. His weight has decreased by an additional 3 pounds, raising concerns about nutritional status and necessitating a closer look at his dietary adherence. Although the pitting edema in his lower extremities remains at 2+, auscultation of the lungs reveals that the bilateral crackles have not worsened, suggesting that fluid accumulation has not progressed significantly.

New laboratory results bring attention to his ongoing renal and metabolic status. Serum creatinine has stabilized at 2.5 mg/dL, offering a slight reassurance that kidney function has not deteriorated further, but the BUN level has slightly increased to 48 mg/dL, requiring ongoing monitoring. Electrolyte panels show persistent hyperkalemia, with potassium levels now at 6.0 mEq/L, posing an increased risk for cardiac complications. Phosphorus remains elevated at 5.4 mg/dL, despite dietary modifications. Additionally, the patient's hemoglobin level has decreased further to 10.8 g/dL, indicating a progression of anemia. Blood pressure readings are averaging 145/90 mmHg, suggesting a need for reevaluation of his antihypertensive regimen.

In response to these findings, the healthcare team discusses the potential benefits of initiating a phosphate binder to help control hyperphosphatemia and considers the need for erythropoiesis-stimulating agents to address anemia. The patient is counseled again on dietary adherence, with a focus on managing potassium and phosphorus intake more effectively. Consideration is given to introducing a nutritionist to tailor a diet plan that meets his caloric needs while managing his renal dietary restrictions. These adjustments aim to stabilize his condition and improve his overall quality of life, while emphasizing the importance of close monitoring and timely intervention in managing chronic kidney disease.

Section 3

Several weeks after the implementation of the revised care plan, the patient returns for another follow-up visit. The healthcare team conducts a comprehensive assessment to determine the patient's response to the interventions. Notably, the patient reports a slight improvement in appetite following the introduction of a phosphate binder, which has helped to alleviate some of the metallic taste. His weight has stabilized, although he has not regained the lost pounds. Importantly, the pitting edema in his lower extremities has reduced to 1+, suggesting a positive response to dietary adjustments and fluid management strategies. However, the patient now reports experiencing occasional palpitations, raising concerns about the ongoing hyperkalemia.

The latest laboratory results reveal a modest reduction in phosphorus levels, now at 4.8 mg/dL, indicating that the phosphate binder is having a beneficial effect. Nevertheless, potassium levels remain elevated at 5.8 mEq/L, necessitating further intervention to mitigate cardiac risks. Hemoglobin levels have increased slightly to 11.2 g/dL following the initiation of an erythropoiesis-stimulating agent, providing some relief from anemia-related symptoms. Blood pressure remains elevated at an average of 140/88 mmHg, prompting a reassessment of his antihypertensive regimen.

Given these findings, the clinical team decides to intensify efforts to manage hyperkalemia, possibly considering the use of a potassium-binding resin and stricter dietary controls to limit potassium intake. The nutritionist collaborates closely with the patient to create a more tailored diet plan, emphasizing foods lower in potassium while ensuring sufficient caloric intake to prevent further weight loss. Moreover, the team plans to monitor cardiac status closely through regular electrocardiograms to detect any arrhythmias early. These steps aim to mitigate new complications, optimize the patient's renal and cardiovascular health, and improve his overall quality of life as he continues to navigate the challenges of chronic kidney disease.

Section 4

Several weeks after the intensified management plan was implemented, the patient returns for another follow-up appointment, presenting with new complications that require immediate attention. During the initial assessment, the patient reports experiencing increased fatigue and shortness of breath, particularly during exertion. He also mentions a persistent dry cough that has developed over the past week. Upon examination, the healthcare team notes mild jugular venous distention and auscultation reveals crackles at the lung bases, raising concerns about possible fluid overload despite previous improvement in edema.

The latest laboratory results show a further elevation in potassium levels, now at 6.2 mEq/L, posing an increased risk for cardiac complications. Additionally, there is a slight decrease in serum sodium levels to 133 mEq/L, which could be contributing to his symptoms of fatigue and confusion. The patient's blood pressure has increased to 150/92 mmHg, suggesting that the current antihypertensive regimen may no longer be effective. In light of these findings, the team considers the possibility of developing congestive heart failure as a complication, likely exacerbated by persistent hyperkalemia and fluid imbalances.

To address these new challenges, the clinical team plans to adjust the patient's diuretic therapy, aiming to achieve better fluid management while monitoring electrolyte levels closely. A cardiology consultation is recommended to evaluate the need for additional cardiac support and to explore further interventions for managing hyperkalemia. The nutritionist revisits the dietary plan, focusing on sodium and potassium restrictions while ensuring adequate nutrition. This comprehensive approach is crucial to stabilizing the patient's condition and preventing further deterioration, underscoring the importance of coordinated care in managing complex cases of chronic kidney disease.

Section 5

As the healthcare team focuses on addressing the fluid overload and hyperkalemia, they initiate an adjustment in the patient's diuretic therapy, transitioning from a potassium-sparing diuretic to a loop diuretic to better manage fluid retention while minimizing further increases in potassium levels. During the first week following this intervention, the patient reports a slight improvement in shortness of breath and a reduction in the frequency of his cough. However, persistent fatigue remains a concern. The team closely monitors the patient's electrolyte levels, noting a gradual decrease in potassium to 5.8 mEq/L and a stable sodium level at 134 mEq/L. These changes, though modest, are encouraging signs of progress in managing the electrolyte imbalances.

During a follow-up visit, the patient's blood pressure is recorded at 142/88 mmHg, indicating a slight improvement but still necessitating ongoing evaluation of the antihypertensive regimen. The cardiology team conducts further assessments, including an echocardiogram, which reveals mild left ventricular hypertrophy and a decreased ejection fraction of 45%, confirming the suspicion of early-stage congestive heart failure. This finding underscores the importance of optimizing cardiac function alongside renal management. Consequently, the team considers adding an ACE inhibitor to address both hypertension and cardiac function, with careful titration to avoid exacerbating renal dysfunction.

In collaboration with the nutritionist, the dietary plan is revised to further restrict sodium and potassium intake while ensuring adequate caloric and protein support to prevent malnutrition. The patient is educated on reading food labels and identifying high-potassium foods to avoid, empowering him to take an active role in managing his condition. The team emphasizes the importance of regular follow-up appointments to monitor his response to these interventions and adjust the treatment plan as needed, aiming to stabilize his condition and enhance his quality of life. As the patient continues on this adjusted care trajectory, the focus remains on preventing complications and promoting optimal health outcomes through coordinated, multidisciplinary care.